🧮 PREVENT Risk Calculator

2025 AHA/ACC Contemporary Cardiovascular Risk Assessment

🆕 Revolutionary Risk Assessment

PREVENT replaces the Pooled Cohort Equations with contemporary data from 3.28 million participants across 46 diverse cohorts, providing more accurate risk prediction for modern populations.

📝 Patient Information

55
200
50
140
90

🎯 Risk Assessment Results

10-Year CV Risk
7.2%
Intermediate Risk

💊 Treatment Recommendation

Consider antihypertensive therapy based on Stage 1 HTN and intermediate risk.

📊 Risk Interpretation

  • <5%: Low risk
  • 5-7.4%: Borderline risk
  • 7.5-19.9%: Intermediate risk
  • ≥20%: High risk

🎯 7.5% Threshold

The 7.5% threshold aligns with statin therapy recommendations, promoting unified cardiovascular risk reduction strategies.

✨ PREVENT Advantages Over Legacy Equations

🕐 Contemporary Data

Based on recent cohorts (2013-2018) vs. Pooled Cohort Equations (1987-2002)

🌍 Diverse Populations

3.28 million participants across 46 cohorts with enhanced racial/ethnic diversity

🏠 Social Determinants

Incorporates ZIP code-based Social Deprivation Index for comprehensive assessment

🫘 Kidney Function

Includes eGFR as independent predictor, enhancing accuracy in CKD patients

📊 PREVENT vs Pooled Cohort Equations Comparison

Feature PREVENT (2025) Pooled Cohort Equations (2017)
Data Source 46 contemporary cohorts (2013-2018) 4 historical cohorts (1987-2002)
Sample Size 3.28 million participants 24,626 participants
Social Factors ZIP code-based Social Deprivation Index Not included
Kidney Function eGFR included as predictor Not included
Modern Therapy Reflects contemporary treatment patterns Pre-statin era data
Validation Validated in multiple external cohorts Overestimated risk in some populations
Age Range 30-79 years 40-79 years

🎯 Clinical Implementation

✅ When to Use PREVENT

  • Stage 1 HTN treatment decisions
  • Shared decision-making discussions
  • Preventive therapy prioritization
  • Patient risk communication

⚠️ Limitations

  • Age restricted to 30-79 years
  • Not validated in all ethnic groups
  • Social Deprivation Index availability varies
  • May not reflect local population characteristics

📚 Verified Sources

PREVENT calculator background and validation papers. [Bibliography added 2026-05-03]

  1. Khan SS, Matsushita K, Sang Y, et al; CKD Prognosis Consortium and AHA Cardiovascular-Kidney-Metabolic Science Advisory Group. Development and Validation of the American Heart Association's PREVENT Equations. Circulation. 2024;149(6):430-449. PMID: 37947085. [Source for: PREVENT equations — AHA cardiovascular-kidney-metabolic risk calculator. Replaces pooled cohort equations.]
  2. Cameron NA, Jones DW, Khan SS, Lloyd-Jones DM. Case-Based Applications of the 2025 AHA/ACC Multispecialty High Blood Pressure Guideline. Hypertension. 2025;82(12):2055-2063. PMID: 41204807. [Source for: 2025 guideline integration of PREVENT for treatment decisions.]
  3. Brown C, Clark D, Jones DW. Updates in the 2025 AHA/ACC Hypertension Guideline. Curr Hypertens Rep. 2026;28(1). PMID: 41843050.

📚 For Educational Purposes Only - Simplified Algorithm for Demonstration

© 2025 University of Dubuque PA Program - All Rights Reserved